Please login to the form below

Not currently logged in
Email:
Password:

essential medicines

This page shows the latest essential medicines news and features for those working in and with pharma, biotech and healthcare.

UCB launches online clinical trial tool

UCB launches online clinical trial tool

Nathalie Vandenbruaene, UCB’s global web manager, said: “As a science-driven company, UCB’s clinical studies are essential to developing new medicines.

Latest news

  • WHO pilots scheme to make biosimilars available to poorer countries WHO pilots scheme to make biosimilars available to poorer countries

    First used for HIV therapies in 2001 the scheme has since been extended to cover a broad range of essential medicines. ... Biosimilars could be game-changers for access to medicines for certain complex conditions," said Suzanne Hill, WHO's director of

  • GSK tops Access to Medicines Index for fifth time running GSK tops Access to Medicines Index for fifth time running

    These efforts mean that more children in the poorest countries are being immunised against deadly diseases; more patients can receive the HIV and asthma medicines they need; and essential healthcare is ... The Access to Medicines Index 2016. View the

  • Pfizer earmarks $350m for first Asian biotech facility Pfizer earmarks $350m for first Asian biotech facility

    In a statement, the head of Pfizer essential medicines division - John Young - said the new facility will "help support China's aim to increase the complexity and value of its manufacturing ... The move comes against a backdrop of considerable change in

  • First-ever World Hepatitis Summit calls for national programmes First-ever World Hepatitis Summit calls for national programmes

    now have medicines that can cure people with hepatitis C and control hepatitis B infection. “ ... Earlier this year WHO added various new hep C drugs to its latest edition of the Model List of Essential Medicines, but also urged pharma companies to

  • Industry files complaint against France's off-label law Industry files complaint against France's off-label law

    A new law in France that allows prescribing of medicines for unapproved uses has been challenged by groups representing Europe's pharmaceutical industry. ... The World Health Organization (WHO) has also backed the drug for AMD, adding the drug to its

More from news
Approximately 3 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Brexit Means Brexit Brexit Means Brexit

    Maintaining membership would, she said, assure a continuation of investment in innovative medicines in the UK. ... Making sure the supply of medicines is uninterrupted is essential to ensure patients in the UK and EU can get the medicines they need from

  • The real-world data conundrum The real-world data conundrum

    Regardless of what the actual total costs are, though, it is certain that, with very few exceptions, the era of blockbuster drugs is over and the demand for stratified medicines, affordable ... diseases. At a more fundamental level, though, availability

  • The EarthWorks: New ways to improve patient care The EarthWorks: New ways to improve patient care

    Improving access to medicines. Demonstrating value in the real world is now central and essential to a medicines value proposition. ... Oncology is a great example of this change, we are working on solutions that manage toxicities for specific medicines

  • Reaching new heights Reaching new heights

    More than 225 medicines will be introduced by 2020, with one-third focused on treating cancer. ... Emerging economies will be focused on providing access and essential medicines to those in need to close endemic healthcare gaps.

  • India has big plans for healthcare and pharma India has big plans for healthcare and pharma

    A budgetary balancing act. More than 100 drugs were this month added to the National List of Essential Medicines, which price caps drugs, impacting pharma shares and adding to uncertainty about ... costs. But the expanding list of essential medicines has

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • EMA’s head of international affairs steps down EMA’s head of international affairs steps down

    The European Medicines Agency's (EMA) Emer Cooke has resigned as head of international affairs, to be replaced ad interim by Agnès Saint-Raymond. ... From mid-November, Cooke will take up the head of regulation of medicines and other health technologies

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

MAT offers an information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics